Publications

5804 Results

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial [PMID18332472]

Authors
EP Mamounas;JH Jeong;DL Wickerham;RE Smith;P Ganz;SR Land;A Eisen;L Fehrenbacher;W Farrar;JN Atkins;ER Pajon;VG Vogel;JF Kroener;L Hutchins;JN Ingle;CE Geyer;JP Costantino;N Wolmark
Journal / Conference
Journal of Clinical Oncology 26(12):1965-1971
Year
2008
Research Committee(s)
Breast
Study Number(s)
CTSU/B-33

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set [PMID:18467725]

Authors
MJ O'Connell;ME Campbell;R Goldberg;A Grothey;J Seitz;JK Benedetti;T Andre;DG Haller;DJ Sargent
Journal / Conference
Journal of Clinical Oncology 26(14):2336-2341
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Summary report 7th annual targeted therapies of the treatment of lung cancer [PMID18449013;PMC3374724]

Authors
L Einhorn;P Bonomi;P Bunn;ER Camidge;DP Carbone;H Choy;S Dubinett;D Gandara;L Gaspar;R Govindan;DH Johnson;J Minna;G Scagliotti;H West;R Herbst
Journal / Conference
Journal of Thoracic Oncology 3:545-555
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0023, S0342, S0533

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen [PMID 18332475]

Authors
PE Goss;J Ingle;JL Pater;S Martino;NJ Robert;HB Ross;MJ Piccart;M Castiglione;LE Shepherd;KI Pritchard;RB Livingston;NE Davidson;L Norton;EA Perez;J Abrams;DA Cameron;MJ Palmer;D Tu
Journal / Conference
Journal of Clinical Oncology 26(12):1948-1955
Year
2008
Research Committee(s)
Breast
Study Number(s)
JMA17

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 [PMID19029412; PMC2645109]

Authors
AC Berger;M Garcia;JP Hoffman;WF Regine;RA Abrams;H Safran;A Konski;A Benson;J Macdonald;CG Willett
Journal / Conference
Journal of Clinical Oncology 26(36):5918-5922
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17

Authors
H Muss;J Ingle;S Martino;N Robert;J Pater;T Whelan;M Palmer;M Piccart;L Shepherd;Z He;P Goss
Journal / Conference
Journal of Clinical Oncology, 26(12):1956-1964
Year
2008
Research Committee(s)
Breast
PMID
PMID18332474
PMC
n/a
Study Number(s)
JMA17

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17 [PMID18332043]

Authors
J Ingle;D Tu;J Pater;H Muss;S Martino;N Robert;M Piccart;M Castiglione;L Shepherd;K Pritchard;R Livingston;N Davidson;L Norton;EA Perez;J Abrams;D Cameron;M Palmer;P Goss
Journal / Conference
Annals of Oncology 19(5):877-882
Year
2008
Research Committee(s)
Breast
Study Number(s)
JMA17

Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197

Authors
L Goldstein;A O'Neill;J Sparano;E Perez;L Shulman;S Martino;NE Davidson
Journal / Conference
Journal of Clinical Oncology 26(25):4092-4099
Year
2008
Research Committee(s)
Breast
PMID
PMID18678836
PMC
PMC2654376
Study Number(s)
E2197

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

Authors
L Goldstein;R Gray;S Bavde;B Childs;C Yoshizawa;S Rowley;S Shak;FL Baehner;P Ravdin;NE Davidson;GW Sledge;E Perez;L Shulman;S Martino;J Sparano
Journal / Conference
Journal of Clinical Oncology 26(25):4063-4071
Year
2008
Research Committee(s)
Breast
PMID
PMID18678838
PMC
PMC2654377
Study Number(s)
E2197

Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group phase II study [PMID: 17530488]

Authors
WE Samlowski;J Moon;JP Kuebler;CR Nichols;DR Gandara;H Ozer;SK Williamson;JN Atkins;DE Schuller;JF Ensley
Journal / Conference
Cancer Investigation 25:182-188
Year
2007
Research Committee(s)
Head and Neck
Study Number(s)
S9902